Week's (Sep 14-18) Metrics and Notes New Stock Purchase, Closed Covered Call

 Here is the week's activities. 

RevGen Trading

- There were no trades made last week. 

KDK Fund

Metrics

Security/ Project	Type	Date of Purchase/Sale	Cost of Investment	EOW Value	Return %
Fuel Cell Energy	Stock	8/3/2020	$2.05	$2.62	27.80%
Silvergate Bank	Stock	8/5/2020	$13.99	$15.98	14.22%
Kintara Therapeutics	Stock	8/21	$1.21	$1.50	23.97%
Microvision	Stock	9/18	$1.67	$1.76	5.39%

Notes

- The September Fuel Cell calls that were sold expired worthless. We now own the stock again and plan to sell another call next week. We are 3 for 3 in the covered call arena and plan to continue using this process to build wealth. 

- A new position in Microvision has been started. We know the company is in a moment of figuring out its direction, with a sale of part or the whole of the company likely. With over 400 patents, and being a leader in the LIDAR space, the current valuation seems low. 

Charity

- The charity will be distributing funds in the next two weeks. 

** This blog is used for opinions and ideas and should not be used as a direction to act without doing your due diligence. As always, we are on Facebook, Twitter, and email through keanevcc@gmail.com**

Metrics and Notes from June 8-12 (Voyager Therapeutics, Virgin Galactic, more)

The following are the metrics and notes for the week of June 8-12.

Metrics

Security/ Project	Type	Date of Purchase	Cost of Investment	EOW Value	Return %
Hive Blockchain	Stock	4/16/2020	$0.22	0.26	18.18%
Social Capital	Stock	5/1/2020	$10.20	10.98	7.65%
Hannon Armstrong	Stock	6/5/2020	30.76	28.27	-8.09%
Microvision	Stock	5/18	$0.93	1.1	18.28%
Virgin Galactic	Stock	6/8	$16.82	14.99	-10.88%
Voyager Therapeutics	Stock	6/11	$12.25	12.13	-0.98%

Notes

Virgin Galactic (story link here) and Voyager Therapeutics (story link here) are new additions to the fund.

Hannon Armstrong announced their quarterly dividend. The story link is here. 

Hive Blockchain has increased its hash rate and mining efficiency. The Yahoo! story link is here.

The fund now has investments mostly covering Climate Change, Blockchain, Cryptocurrency, DNA Therapeutic Research, Exploration, Lidar, and US based Tech. 


**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

May 25-29 Perforance and Notes (Hive Blockchain, Social Capital, more)

Here are some metrics and notes on the fund's holdings.

Security/ Project	Type	Date of Purchase	Cost of Investment	Current Value	Return %
Hive Blockchain	Stock	4/16/2020	$0.16	0.27	68.75%
Social Capital	Stock	5/1/2020	$10.20	10.63	4.22%
Fuel Cell Energy	Stock	5/3	$2.01	2.13	5.97%
Microvision	Stock	5/18	$0.93	0.88	-5.38%

Notes

- No purchases or sales during the week.
- No earnings were released during the week.
- Microvision has regained Nasdaq value requirement while still working on the $1.00 price per share requirement.
- Microvision is the subject of a dispute as to a possible SEC investigation on Seeking Alpha. It is in regards to possible NDA with Microsoft.


**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

May 18 - 22 Performance (IBio Inc., Microvision, Fuel Cell Energy, more)

Here are some metrics and notes for the fund's activity during May 18 - 22.

Security/ Project	Type	Date of Purchase	Cost of Investment	Current Value	Return %
Hive Blockchain	Stock	4/16/2020	$0.16	0.26	62.50%
Social Capital	Stock	5/1/2020	$10.20	10.6	3.92%
Fuel Cell Energy	Stock	5/3	$2.01	1.98	-1.49%
Microvision	Stock	5/18	$0.93	0.98	5.38%

- The fund sold its stock in IBio as the value of the investment increased over 60%.

- A position has been started in Microvision again at $0.93. A link to the story is here.
- More shares of Fuel Cell Energy have been purchased.



**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Microvision Stock Purchased

This week, the fund has started a position in Microvision. We believe the stock of the company has the opportunity to reach $2.00 before the end of the year. Some notes are below.

- The company had a good conference call on May 7th.

- One of the company's products was also found in Microsoft's Hololens 2. The link to that story can be found here. 

- The company is still using Craig-Hallum Capital Group LLC as a financial advisor.


**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

May 4-8 Performance (Crispr, Microvision, Hive Blockchain, Social Capital, Fuel Cell Energy)

Here are some metrics and notes for the week of May 4-8.

Security/Project	Type	Date of Purchase	Cost of Investment	Current Value	Return %
Crispr Therapeutics	Stock	3/23/2020	$38.78	53.81	38.76%
Hive Blockchain	Stock	4/16/2020	$0.16	0.33	106.25%
Social Capital	Stock	5/1/2020	$10.20	10.34	1.37%
Fuel Cell Energy	Stock	5/3	$1.93	2.1	8.81%

- Sold position in Microvision. Story link here.
- Started position in Fuel Cell Energy. Story link here.
- Bitcoin is back around $10,000 with halving coming up later this month (affecting Hive Blockchain position). 



**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Sold Remaining Microvision Shares

With some surprise, Microvision's stock price hit our target. With another opportunity staring at us, we have decided to sell the remaining shares at $0.94. The total profit for the 2 months the shares were held was over 300%. This was not expected.

Proceeds will go to taxes, KeaneVCC charity, investors and the rest will be put back into the account.


   **All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Portfolio Weekly Performance (Crispr, Microvision, Hive Blockchain, Social Capital)

Here are some metrics and some activity notes.

Security/Project	Type	Date of Purchase	Cost of Investment	Current Value	Return %	Notes
Crispr Therapeutics	Stock	3/23/2020	$38.78	54.01	39.27%
Microvision	Stock	3/23/2020	$0.00	0.44	100.00%	Sold Cost portion. All Profit at this point
Hive Blockchain	Stock	4/16/2020	$0.16	0.23	43.75%
Social Capital	Stock	5/1/2020	$10.20	10.19	-0.10%

- Crispr released earnings this past week. Story link can be found here.
- Sold 1/2 of Microvision stock. Story here.
- Microvision releasing earnings this week. 
- Bought Social Capital. Story here. 



 **All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

1/2 Position in Microvision Sold

The fund has sold 1/2 of its position in Microvision. Some of the reasons are below.

- The price of Microvision rose to $0.40.
- Selling 1/2 the position protects capital, leaving the rest as profit
- There are other opportunities for the capital



**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Portfolio Performance (Crispr, Microvision, Hive Blockchain)

Here are some metrics and notes on the portfolio. The portfolio reflects the performance of the resources available executing the mission of KDK Fund.  

Security/Project	Type of Investment	Date of Investment Purchase	Cost of Investment	Current Value of Investment	Return %
Crispr Therapeutics	Stock	3/23/2020	$38.78	54.01	39.27%
Microvision	Stock	3/23/2020	$0.18	0.25	38.89%
Hive Blockchain	Stock	4/16/2020	$0.16	0.23	43.75%

Week's Notes

- Crispr Therapeutics - will likely be announcing earnings on April 27th.

- Hive Blockchain - Bitcoin halving in May 2020 (definition of halvening through Gemini Capital found here).

- Microvision - Company shareholder meeting on May 19th, 2020 (link here).

- The fund will continue to look for opportunities to improve the fund. The next likely entry into the portfolio will be energy related.


**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Hive Blockchain Added to Portfolio

Hive Blockchain shares have been added to the portfolio.We currently feel that with the current resources available, this is the right move to be in the blockchain space. Hive Blockchain has the management experience, the existence in a growing market, and access to resources needed to build wealth for its stakeholders. The plan is to hold and likely add shares to the portfolio going forward. 

From the company's website - Simply put, HIVE is a cryptocurrency mining firm. We validate transactions on blockchain networks — like Ethereum — for rewards paid in cryptocurrencies. Everyday HIVE earns new crypto coins which it can monetize for revenue and cash flow. HIVE offers shareholders exposure to the operating margins from cryptocurrency mining plus a growing portfolio of coins.


KDK Fund looks to provide capital (financial, consulting, etc.) resources to companies and projects it deems are improving life's existence. The portfolio also has an equity stake in Crispr Therapeutics (post here), and Microvision (post here).  


 **All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Microvision Added To Portfolio

Microvision shares have been added to the portfolio.

The company's focus is on using it PicoP (trademarked) technology. Our technology allows us to create high resolution miniature projection displays and LiDAR sensors.

With the amount of patents, and the value that the technology brings, we thought it would be a good speculative investment. Shares were purchased for $0.17 per share. The fund likes the Lidar technology that is pushing the automotive industry forward in self driving vehicles, which we believe will upend everything from oil to insurance to local government revenue (story here).

The portfolio looks to invest in companies that will push life's existence in a positive direction. The portfolio also has an equity stake in Crispr Therapeutics (post here).  


 **All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.